Saito Takashi, Takaori-Kondo Akifumi, Tashima Masaharu, Yamashita Kohei, Iinuma Yoshitsugu, Takakura Shunji, Nagao Miki, Ichinohe Tatsuo, Ishikawa Takayuki, Uchiyama Takashi, Ichiyama Satoshi
Department of Clinical Laboratory Medicine, Kyoto University Hospital, Shougoin, Kyoto, Japan.
Int J Hematol. 2009 Jun;89(5):689-92. doi: 10.1007/s12185-009-0278-5. Epub 2009 Mar 24.
The incidence of multidrug-resistant Pseudomonas aeruginosa (MDRPA) and metallo-beta-lactamase (MBL)-producing P. aeruginosa has increased worldwide. The treatment options are limited for infectious diseases caused by these two organisms. The use of colistin has been of recent interest in cases involving both types. We report the case of a 74-year-old man with acute myeloid leukemia who was successfully treated with intravenous colistin for maxillary sinusitis and orbital cellulites due to MBL-producing MDRPA during neutropenia, and then for pneumonia caused by the bacteria after the recovery of neutrophil counts.
多重耐药铜绿假单胞菌(MDRPA)和产金属β-内酰胺酶(MBL)的铜绿假单胞菌的发病率在全球范围内都有所上升。这两种病原体引起的传染病治疗选择有限。近年来,黏菌素在涉及这两种病原体的病例中受到关注。我们报告了一例74岁急性髓系白血病男性患者,在中性粒细胞减少期间,因产MBL的MDRPA导致上颌窦炎和眼眶蜂窝织炎,成功接受静脉注射黏菌素治疗,中性粒细胞计数恢复后,又因该细菌引起的肺炎接受了治疗。